Enovis Corporation

Enovis Corporation is a medical technology company that develops clinically differentiated solutions for musculoskeletal health. It operates through two segments: Prevention and Recovery, and Reconstructive. The Prevention and Recovery segment offers orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems, compression garments, electrical stimulators for pain management, and physical therapy products. These are used by orthopedic specialists, surgeons, physical therapists, and other healthcare professionals to treat musculoskeletal conditions. The Reconstructive segment provides surgical solutions including implants, instrumentation, and enabling technologies for joint replacement, limb reconstruction, and foot and ankle procedures. Products cover hip, knee, shoulder, elbow, extremity reconstruction, and surgical productivity tools.

Enovis Corporation is listed on the New York Stock Exchange (NYSE) under the ticker symbol ENOV. Its shares are traded in US Dollars (USD), as the company is based in the United States. The exchange and currency reflect its primary listing in the US market, providing investors with access to its stock in the world's largest equity market.

Enovis Corporation operates in the Healthcare sector, specifically within the Medical Devices industry. As a medical technology company, it focuses on developing and distributing products for musculoskeletal health, including orthopedic braces, surgical implants, pain management devices, and rehabilitation equipment. The Medical Devices industry involves the design, manufacture, and sale of devices used in diagnosis, treatment, and patient care, and Enovis's products are used by healthcare professionals in hospitals, clinics, and rehabilitation centers.

Enovis Corporation is headquartered in the United States and serves markets globally, including the United States and international regions. The company's products are distributed through independent distributors, direct salespeople, and directly to patients. Its medical devices are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, and athletic trainers worldwide. The company's global reach allows it to address musculoskeletal conditions across diverse healthcare systems.

Enovis Corporation generates revenue through the sale of medical devices and products across two segments. The Prevention and Recovery segment sells rigid and soft orthopedic bracing, hot and cold therapy products, bone growth stimulators, vascular therapy systems, compression garments, electrical stimulators for pain management, and physical therapy products. The Reconstructive segment sells surgical implants, instrumentation, and enabling technologies for joint replacement, limb reconstruction, and foot and ankle procedures. Products are distributed via independent distributors, direct salespeople, and directly to patients. The company's revenue comes from both elective and non-elective procedures, as well as rehabilitation and pain management treatments.